Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Nicholson

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Personality Assessment|January 11, 2005
Distinguishing bipolar depression, major depression, and schizophrenia with the MMPI-2 clinical and content scalesR Michael Bagby, Margarita B Marshall, Michael R Basso, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Headache|June 15, 2005
Future directions in behavioral headache research: applications for an evolving health care environmentDonald B Penzien, Jeanetta C Rains, Gay L Lipchik, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Unintended effects of emphasizing disparities in cancer communication to African-AmericansRobert A Nicholson, Matthew W Kreuter, Christina Lapka, et al.
Neurology and Therapy|August 2, 2025
Patient Preferences for Self-Injectable Preventive Treatment for Migraine: A Multi-country Discrete Choice ExperimentJaein Seo, Caitlin Thomas, Tommi Tervonen, et al.
BMC Neurology|March 13, 2025
Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) studyRobert E Shapiro, Lars Viktrup, Eva Jolanda Muenzel, et al.
Headache|January 7, 2026
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) studyJessica Ailani, Rose Okonkwo, Elizabeth Johnston, et al.
Headache|March 14, 2025
Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) studyDawn C Buse, E Jolanda Muenzel, Anthony J Zagar, et al.
The Patient|June 16, 2021
Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group StudyJaein Seo, Charlie A Smith, Caitlin Thomas, et al.
Headache|February 20, 2026
Unmet treatment needs in migraine: Results of the OVERCOME (US) studySusan Hutchinson, Elizabeth Johnston, Robert A Nicholson, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Personality Assessment|January 11, 2005
Distinguishing bipolar depression, major depression, and schizophrenia with the MMPI-2 clinical and content scalesR Michael Bagby, Margarita B Marshall, Michael R Basso, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Headache|June 15, 2005
Future directions in behavioral headache research: applications for an evolving health care environmentDonald B Penzien, Jeanetta C Rains, Gay L Lipchik, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Unintended effects of emphasizing disparities in cancer communication to African-AmericansRobert A Nicholson, Matthew W Kreuter, Christina Lapka, et al.
Neurology and Therapy|August 2, 2025
Patient Preferences for Self-Injectable Preventive Treatment for Migraine: A Multi-country Discrete Choice ExperimentJaein Seo, Caitlin Thomas, Tommi Tervonen, et al.
BMC Neurology|March 13, 2025
Stigmatizing attitudes toward people with migraine by people without active migraine: results of the OVERCOME (US) studyRobert E Shapiro, Lars Viktrup, Eva Jolanda Muenzel, et al.
Headache|January 7, 2026
Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) studyJessica Ailani, Rose Okonkwo, Elizabeth Johnston, et al.
Headache|March 14, 2025
Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME (US) studyDawn C Buse, E Jolanda Muenzel, Anthony J Zagar, et al.
The Patient|June 16, 2021
Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group StudyJaein Seo, Charlie A Smith, Caitlin Thomas, et al.
Headache|February 20, 2026
Unmet treatment needs in migraine: Results of the OVERCOME (US) studySusan Hutchinson, Elizabeth Johnston, Robert A Nicholson, et al.
Pageof 5